John David Hansen, PRESIDENT AND CEO at MABVAX THERAPEUTICS HOLDINGS, INC. (MBVX), sold 5,051 shares at $2.25 ($11K) on 2017-04-04, disclosed to the SEC on 2017-04-06.
Open-market sale of $11k MBVX by PRESIDENT AND CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.25 | 1,100 | $2K | 22.6% |
| 2 | $2.15 | 2,450 | $5K | 48.0% |
| 3 | $2.15 | 1,501 | $3K | 29.4% |
| Total | $2.17 avg | 5,051 | $11K | 100% |
| Filing → |
| MBVX | BUY | 2017-08-02 | $8K | — | Filing → |
| MBVX | SELL | 2017-04-14 | $20K | — | Filing → |
| MBVX | SELL | 2017-04-11 | $3K | — | Filing → |